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An optimised tissue disaggregation 
and data processing pipeline 
for characterising fibroblast 
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sequencing
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Jonathan West  1,2, Christian H. ottensmeier  1,3, Gareth J. thomas1 & Christopher J. Hanley1
Single-cell RNA sequencing (scRNA-Seq) provides a valuable platform for characterising multicellular 
ecosystems. Fibroblasts are a heterogeneous cell type involved in many physiological and pathological 
processes, but remain poorly-characterised. Analysis of fibroblasts is challenging: these cells are difficult 
to isolate from tissues, and are therefore commonly under-represented in scRNA-seq datasets. Here, 
we describe an optimised approach for fibroblast isolation from human lung tissues. We demonstrate 
the potential for this procedure in characterising stromal cell phenotypes using scRNA-seq, analyse the 
effect of tissue disaggregation on gene expression, and optimise data processing to improve clustering 
quality. We also assess the impact of in vitro culture conditions on stromal cell gene expression and 
proliferation, showing that altering these conditions can skew phenotypes.
In recent years, a number of platforms to perform single cell RNA sequencing (scRNA-seq) have been developed. 
These technologies facilitate analysis of biological processes at a previously unachievable resolution, providing 
novel insights into the multicellular ecosystems present in normal tissues and pathogenic processes1–4. However, 
to harness the full potential of this approach, a number of technical obstacles must be overcome.
The first consideration for scRNA-seq is the approach used to generate the single-cell suspension for analysis. 
Suspensions generated using mechanical and/or enzymatic protocols may not accurately mirror the tissue of 
origin. Lengthy or over-vigorous disaggregation may alter gene expression in cells5, confounding downstream 
analysis. In addition, some populations (e.g. epithelial and stromal cells) are often relatively under-represented 
in scRNA-seq3. Fibroblasts, almost ubiquitous in human tissues, are embedded within extracellular matrix and 
are particularly difficult to isolate. This heterogeneous cell population6–15 plays a major role in tissue homeostasis 
and disease pathogenesis, including cancer progression16–19. However, fibroblasts remain a poorly-defined group: 
commonly-used fibroblast markers (α-smooth muscle actin, α-SMA; platelet-derived growth factor, PDGFR; and 
fibroblast activation protein-α, FAP-α) are also expressed on other cell types20,21. While fibroblasts are relatively 
straightforward to culture ex vivo, it is unclear whether standard approaches22,23 retain the distinct fibroblast 
phenotypes found in vivo6–15. In order to accurately characterise fibroblast subtypes and investigate functional 
differences, precise phenotyping at a single-cell resolution is required.
Filtering out low-quality events (such as sequenced cell fragments, or cells sequenced in insufficient depth) is 
an essential quality-control step prior to downstream analysis of scRNA-seq data. The approach used to perform 
filtering is not standardised and varies considerably between studies, potentially compromising reproducibil-
ity. Variability can be attributable to inherent differences in data generated by different platforms. For exam-
ple, due to the greater sequencing depth afforded by SMART-seq224, the lowest acceptable number of genes per 
cell (nGene) for datasets generated using this platform will be considerably higher than for data generated with 
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droplet-based technologies (e.g. 10X and Drop-Seq)1,3. The relative affordability and commercial availability of 
droplet-based platforms have resulted in these approaches becoming increasingly popular. However, their rela-
tively low sequencing depths means that identification of low-quality cells can be challenging, particularly when 
analysing mixed cell type populations.
Here, we compare previously-described approaches for tissue disaggregation. We determine the optimal 
method for stromal cell isolation from primary human lung tissue (allowing immediate analysis without in vitro 
culture) and refine the single-cell bioinformatic analysis pipeline for our data. We also examine how in vitro cul-
ture alters the transcriptomes of isolated primary fibroblasts, and assess the impact of altering culture conditions 
on fibroblast phenotype.
Results
Disaggregation enzymes and incubation times have a significant impact on stromal cell isola-
tion. Flow cytometry was used to determine the fraction of fibroblasts isolated from lung tissues using differ-
ent enzyme cocktails. To optimise fibroblast identification, we excluded immune (CD45+), epithelial (EpCAM+) 
and endothelial (CD31+) cells, and compared the expression of three previously-described fibroblast surface 
markers (PDGFR-α and -β, CD90) in foetal lung (IMR-90) and skin (HFFF2) fibroblasts and also a lung cancer 
cell line (H441). CD90 was found to be a robust marker of lung fibroblasts with greater sensitivity and speci-
ficity than PDGFR-α alone, or in combination with PDGFR-β, and was therefore used in all further analyses 
(CD90: 99.2% positivity with 1175-fold increase in mean fluorescence intensity compared to the negative control; 
PDGFR-α: 4.1% positivity with 4.6-fold increase in mean fluorescent intensity (MFI); and PDGFR-α with –β: 
9.2% positivity with 19-fold increase in MFI; Fig. S1).
We next examined the effect of disaggregation time and different protease cocktails (Collagenase P, Liberase 
DL, TL and TM) on fibroblast isolation from lung tissues. Shorter disaggregation times (15 minutes) and lower 
protease-strength enzymes (Liberase DL, TL and TM) were insufficient to isolate stromal cells; instead yield-
ing high proportions of immune cells (CD45+). In contrast, tissue digestion with Collagenase P for 60 min-
utes resulted in a greater diversity of cell types isolated (Fig. 1a), with a significantly lower proportion (p = 0.03) 
of CD45+ cells and a significantly higher proportion (p = 0.01) of CD45-EpCAM-CD31-CD90+ cells (i.e. 
fibroblasts; Fig. 1b,c). There was no significant change in the fractions of CD45-EpCAM+ (epithelial) or 
CD45-EpCAM-CD31+ (endothelial) cells (Fig. S2a,b). Dissociation enzyme and duration did not significantly 
affect cell yield or viability (Fig. S2c,d).
Unexpectedly, analysis also revealed that epithelial cells represented a low proportion of the cells isolated. We 
hypothesised that this was due to tight intercellular interactions between these cells, with resulting cell aggregates 
removed during filtration or at FACS analysis. To test this, following Collagenase P incubation for 60 minutes, 
single cell suspensions were additionally incubated with TrypLE (Thermo Fisher) at 37 °C for 10 minutes. This 
yielded a significantly higher proportion of epithelial cells (Fig. 1d), accompanied by a reduced immune cell frac-
tion (Fig. S3a). Percentages of endothelial cells and fibroblasts were not significantly affected (Fig. S3b,c).
Lung tissue disaggregation with Collagenase P for sixty minutes is compatible with single-cell 
RNA sequencing using the Drop-seq platform. Development of scRNA-Seq has facilitated identifica-
tion of novel mesenchymal sub-populations in, for example, murine lung4. To determine the compatibility of our 
optimised disaggregation protocol with this approach to gene expression profiling, we processed primary human 
tissue (from a lung affected by granulomatous inflammation) and captured single-cell transcriptomes using 
Drop-seq25. Quantification and fragment analysis of PCR-amplified cDNA (Fig. S4) in these samples confirmed 
the successful capture of full-length transcripts (up to 5 Kb, suggesting that mRNA integrity was unaffected).
Identifying and removing low-quality droplets. There are currently no standardised approaches for 
this pre-processing step, and filtering thresholds vary between studies1,3. We therefore sought to develop a gen-
eralisable approach to pre-processing droplet-based scRNA-Seq data, in order to improve filtering and thus cell 
type identification by unsupervised clustering. Baseline clustering quality was assessed using unfiltered data. This 
identified 17 clusters, with an average silhouette width of 0.45 (Fig. 2a). We also applied previously-described 
pre-processing steps (removing cells with more than 15000 or fewer than 200 nUMIs, over 5000 or below 100 
genes, or over 20% of reads mapping to mitochondrial genes)1–3, finding that this improved clustering quality 
(average silhouette width 0.51; Fig. 2b).
Due to the lower read depth associated with droplet-based sequencing platforms, distinguishing low-quality 
droplets from true cells with a low nGene (e.g. lymphocytes3) is challenging. This is further complicated by the 
absence of ‘ground truth’ labels for low- and high-quality events for these technologies. To determine the optimal 
approach, we examined the variation of a range of QC metrics between events assumed to be low-quality (nGene 
less than 100) and those likely to represent true cells (nGene between the median and 2.5 MAD above the median; 
Fig. S5a). QC metrics comprised: nUMI, the percentage of reads mapping to mitochondrial (percent mito) or 
ribosomal genes (percent ribo), the ratio between these two values, and housekeeping gene expression. We addi-
tionally defined an algorithm to estimate the contribution of both reads and genes detected due to encapsulation 
of ‘ambient’ RNA (described in the Materials and methods section). Each of these metrics showed a significant 
difference between the low-quality droplets and true cells (Bonferroni corrected p < 0.0001 Fig. S5b–h).
To harness the predictive power of each variable, we trained a machine learning (random forest26) model to 
distinguish between the low-quality droplet and true cell groups. The data was divided at random into ‘train-
ing’ and ‘test’ datasets (in a ratio of 3 to 1). When applying the trained classifier to the ‘test’ dataset, ‘cells’ were 
detected at a sensitivity and specificity of 100%. Analysing the relative importance of each metric in the classifier27 
showed that the ratio between the number of the sample specific highly expressed genes detected and total num-
ber of genes detected (ssHEGs:nGene.genes) was the most important variable in distinguishing between cells and 
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low-quality droplets (Fig. 2d). Highlighting the droplets identified as low-quality by the classifier, on a log(nUMI) 
vs. log(nGene) plot (Fig. 2e), illustrates that this machine learning approach to filtering provides greater sen-
sitivity than filtering using hard thresholds for individual QC metrics. Cell-cell doublets were identified on an 
nUMI vs. nGene plot (Fig. S2f) and removed from downstream analysis. Dead or dying cells can also impact 
downstream analysis; percent mito is known to be an effective measure of this process in scRNA-Seq data28. We 
removed cells with a percent mito greater than 2.5 MAD above the median (Fig. 2g). This combined approach 
further improved the quality of clustering (average silhouette width 0.58; Fig. 2c).
Assessing the impact of extended enzymatic disaggregation times on transcriptomic data. 
Analysis of the scRNA-seq data confirmed that disaggregation for 60 minutes yields a greater fraction of stromal 
cells (as well as more even coverage of other cell types) than disaggregation for 15 minutes (Fig. 3a). However, 
previous authors have shown that enzymatic disaggregation can lead to changes in gene expression, describing 
a disaggregation-associated gene signature (derived using murine stem cells)5. We assessed the effect of apply-
ing this signature to our data: as expected, its expression was increased in samples disaggregated for 60 minutes 
Figure 1. Disaggregation enzymes and incubation times have a significant impact on stromal cell isolation. 
(a) Representative pie charts for each disaggregation time and enzyme cocktail. (b–d) Dot plots showing cell-
type fractions isolated by different disaggregation procedures across human patient samples (n = 5): fibroblasts 
(CD45-EpCAM-CD31-CD90+: b), Immune cells (CD45+: c), and epithelial cells (CD45-EpCAM+: d; 
*p < 0.05, unpaired two-tailed t-test). Further data associated with this figure can be found in Figs S1–4.
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compared to those processed for 15 minutes (Fig. 3c). However, we found that this signature did not appear to 
impact cell clustering, and was not a prominent feature of any individual cluster (Fig. S6a).
As the gene signature proposed by van den Brink et al. was derived from murine experiments and includes 
previously-described markers for human cell types, we sought to refine this signature based on our analysis. 
We therefore cross-referenced the genes in this signature with those upregulated (p < 0.001, average log10(fold 
change) > 1) following disaggregation for 60 minutes vs. 15 minutes, excluding those identified as cell type mark-
ers. This identified a list of eleven genes which were consistently upregulated following extended disaggregation, 
and were not upregulated by a particular cell type (Fig. 3b). We applied this list to our data as a refined disaggre-
gation signature.
The distribution of expression of this signature in our dataset is shown in Figs 3d and S6b. Clusters 0, 4 and 9 
(representing T cells, B cells and mast cells) show higher expression, indicating that some cell types may be more 
sensitive to extended enzymatic disaggregation than others. However, none of the principle components used for 
clustering correlated with this gene signature (ρ < 0.23). It is therefore unlikely that disaggregation-associated 
gene changes have impacted cell clustering. Removal of cells with high expression (greater than 2.5 MAD above 
the median) of this signature did not improve clustering quality (maximum average silhouette width 0.56 vs. 0.58 
prior to filtering). However, the potential impact of extended enzymatic disaggregation on cellular transcriptomes 
should be considered when analysing such data: in particular, where particular cell populations appear to be 
defined by high expression of a disaggregation-associated signature.
Figure 2. Standardised quality-control metrics improve clustering quality of scRNA-seq data. tSNE plots 
showing principle component-based clustering and average silhouette width for: (a) unfiltered data, (b) data 
filtered using widely-used quality-control metrics and (c) the optimised approach described here (shown in 
d–g). Each point represents an individual cell, groups of cells with similar transcriptomes are referred to as a 
‘cluster’ and distinguished by colour. Fibroblast populations are encircled in black. (d–g) Cell filtering using our 
optimised processing pipeline: (d) Multi-way importance plot showing the relative importance of each metric 
in distinguishing between low-quality events and droplets, (e) Plot of log(nGene) vs. log(nUMI). Data points 
identified as low-quality events are highlighted in red, (f) Plot of nUMI vs. nGene. The red line indicates the 
upper nGene threshold (defined as 2.5 MAD above the median) and (g) Plot of nGene vs. percent mito. The red 
line indicates the upper threshold (defined as 2.5 MAD above the median). Further data associated with this 
figure can be found in Fig. S5.
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In vitro culture alters transcriptomes. Recent studies have shown that the gene expression profiles of 
cancer-associated fibroblasts are significantly altered by culture in vitro1,2. We cultured primary fibroblasts iso-
lated from tumour and non-involved tissue in vitro for one passage and compared gene expression profiles to 
those of fibroblasts analysed immediately following disaggregation (“ex vivo”), and a lung foetal fibroblast cell 
line (IMR-90). We found that fibroblasts isolated from tumour or non-involved tissues show differential gene 
expression following culture in vitro for one passage (Fig. 4a). Gene expression by these cells more closely resem-
bles IMR-90 cells than ex vivo fibroblasts (Fig. 4b), showing that culture on plastic surfaces causes significant 
transcriptomic changes in primary lung fibroblasts.
3D in vitro culture significantly alters gene expression and can be used to skew fibroblast phe-
notypes towards previously described sub-types. To determine whether ex vivo fibroblast phenotypes 
can be recapitulated or retained by manipulation of in vitro conditions, we cultured primary fibroblasts either 
on plastic or in collagen-Matrigel® 3D gels. Cells were harvested after five days and changes in gene expression 
measured using real-time PCR.
Alteration of culture conditions had a significant impact on the expression of genes associated with 
previously-described fibroblast subtypes (Fig. 4c–f; these genes were also found to be differentially expressed 
between ex vivo and in vitro fibroblasts; Fig. 4a and Table 1). Expression of ACTA2, COL1A1 and COL3A1 (mark-
ers of myofibroblast transdifferentiation29,30) were significantly increased in fibroblasts grown in 2D, whereas 
expression of IL6 (a marker of ‘inflammatory’ fibroblasts31) was significantly increased in 3D. However, 3D cul-
ture conditions were not sufficient to recover ex vivo fibroblast gene expression: CFD and MGP (genes which were 
upregulated in ex vivo fibroblasts) showed significant downregulation and a non-significant reduction in expres-
sion, respectively (Fig. 4f,g). None of the investigated genes showed significant differential expression between 
fibroblasts from normal (NOF) or tumour (CAF) samples or across patients (Fig. S8). The changes in expression 
of COL1A1, SMA and IL6 were found to be maintained at the protein level (Fig. S9).
Discussion
Fibroblasts are a heterogeneous population in both normal and disease states16,30,32,33. Here, we describe a protocol 
for isolation of stromal cells by disaggregation of primary human lung tissues, enabling these cells to be analysed 
directly ex vivo. In addition, this protocol may be modified to isolate other cell types: addition of TrypLE gener-
ates a significantly higher fraction of epithelial cells without affecting the proportions of stromal cells. We also 
examine the effect of tissue disaggregation on gene expression, and optimise pre-processing of scRNA-Seq data. 
Having applied these approaches, we additionally demonstrate that culturing fibroblasts in vitro significantly 
impacts molecular phenotype: this has important consequences for functional analysis of these cells from normal 
and pathological tissues.
Figure 3. Longer tissue disaggregation enables detection of more cell types, with concomitant increases in 
disaggregation-associated changes in gene expression. (a) Stacked barplot showing cell type fractions generated 
by disaggregation for 15 and 60 minutes. (b) Venn diagram showing overlap between murine disaggregation-
associated signature5 (Murine DAG), human disaggregation-associated signature (Lung DAG) and cell type 
markers. The 11 genes comprising the refined signature (highlighted in bold) are shown on the right. (c) and 
(d) Density plots showing percentage expression of the murine disaggregation signature (c) and the refined 
disaggregation signature (d), in human lung tissue disaggregated for 15 and 60 minutes. Further data associated 
with this figure can be found in Fig. S6.
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In keeping with recent findings3, our results show that extended Collagenase incubation times are required 
to release fibroblasts from tissue samples. In contrast, non-adherent cells (such as immune cells) are readily and 
rapidly isolated by enzymatic disaggregation. Although prolonged incubation with bacterial Collagenases has 
been reported to cause cellular damage through proteolysis34, we did not observe any significant differences in 
cell viability between the conditions investigated here. The described protocol is therefore likely to be a superior 
Figure 4. In vitro culture alters fibroblast transcriptomes. (a) Volcano plot of genes differentially expressed 
(log(fold change) >1) between in vitro and ex vivo fibroblasts. Genes selected for analysis at real time-PCR are 
highlighted in red. (b) Dendrogram showing unsupervised hierarchical clustering of average gene expression 
for the four cell populations. (c–g) Dot plots showing changes in gene expression (real-time PCR) in primary 
lung fibroblasts following culture on plastic or in 3D (collagen:Matrigel gels): (c) ACTA2, (d) COL1A1, (e) 
COL3A1, (f) IL6, (g) CFD and (h) MGP. Gene expression levels expressed as the log2 fold change relative to 
mean expression across all samples (n = 4). ▲: NOF, ♦: CAF. *p < 0.05, ***p < 0.001, ****p < 0.0001, unpaired 
or Welch’s t-tests. Further data associated with this figure can be found in Figs S7–S9.
Gene Average log(fold change) Adjusted p value
ACTA2 −1.51 5.93 × 10−9
COL1A1 −1.60 2.60 × 10−15
COL3A1 −1.81 3.94 × 10−20
IL6 1.51 1.88 × 10−13
CFD 2.41 2.65 × 10−13
MGP 2.92 2.20 × 10−25
Table 1. Summary of key genes differentially expressed between ex vivo and in vitro fibroblasts.
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method for cell isolation compared with mechanical disaggregation alone: although mechanical disaggregation 
preserves surfaces markers, this approach has been reported to give lower cell yield and viability35,36.
Previous authors have described a disaggregation-associated gene signature, based on the changes in gene 
expression induced by prolonged enzymatic disaggregation5. As this signature was derived from murine muscle 
stem cells, we sought to determine its’ applicability to human lung tissues. We found eleven genes from this signa-
ture that were both upregulated in cells isolated from human lung tissues following prolonged disaggregation, and 
not identified as cell type markers. As these genes were conserved across both species and tissues, we suggest that 
this refined gene list represents a robust disaggregation-associated signature. We propose that this signature will 
assist in distinguishing true clusters from those arising due to disaggregation-induced changes in gene expression. 
Accounting for this phenomenon is likely to be critical when attempting to identify cell subpopulations. This 
signature may be used either to filter out all cells with high expression, or to exclude principle components which 
correlate with disaggregation-associated gene expression changes from downstream cell clustering.
Enzymatic disaggregation can impact surface marker expression through indiscriminate protease activity35–37. 
This may limit its use for certain downstream assays (e.g. immunophenotyping by flow cytometry) if the markers 
of interest are susceptible to proteolytic cleavage by the Collagenase P enzyme cocktail. However, changes in the 
expression of surface proteins are not reflected by a corresponding change in mRNA, and are unlikely to significantly 
impact single-cell RNA sequencing or longer-term tissue culture. For example, expression of CDH1 (the gene encod-
ing E-cadherin, a surface protein susceptible to protease cleavage38) is detectable in our epithelial cell populations.
Regardless of the platform used, scRNA-seq data requires quality-control measures to remove low-quality 
events. There are currently no standardised approaches for this pre-processing step, and filtering thresholds 
vary between studies1,3. Routinely-applied quality control metrics used for filtering low-quality events include 
exclusion of cells with a low number of genes sequenced (nGene; removing sequenced cell fragments) or a high 
percentage of reads mapping to mitochondrial genes (‘percent mito’, indicative of burst cells that have lost cyto-
plasmic contents and dead or dying cells). Single-cell platforms are also known to be affected by cell doublets: 
where libraries are sequenced from co-isolated, rather than single, cells24,25. These events are easily identified as 
outliers for nGene on a plot of nUMI vs. nGene.
We developed a standardised, generalisable method using a machine learning (random forest) approach to 
identify low-quality droplets based on a number of metrics. This enables removal of low-quality events from fur-
ther analysis and improved clustering quality when compared with the most commonly-used current approaches.
A number of studies have demonstrated that mechanical changes to tissue culture substrates can impact fibro-
blast phenotypes39–42, yet the vast majority of research analysing these cells is still performed on plastic. We found 
that culturing fibroblasts in vitro causes a significant shift in phenotype compared to that seen immediately fol-
lowing isolation, consistent with previous studies1,2. This emphasises the importance of profiling cells directly 
from tissues to characterise accurately in vivo phenotypes.
Notably, we also show that fibroblasts show differential expression of genes associated with previously-described 
phenotypes when cultured in 2D or 3D. For example, primary human fibroblasts cultured on plastic surfaces 
showed increased expression of COL1A1 and COL3A1, which are associated with a ‘myofibroblastic’ phenotype. 
In contrast, culturing these cells in 3D resulted in significantly increased expression of IL6, which may be indica-
tive of an ‘inflammatory’ CAF phenotype31. The skewing of phenotypes induced by culture conditions needs to be 
taken into account when drawing conclusions from in vitro studies of fibroblast function.
Recent technological advances, such as Drop-seq, have enabled precise transcriptomic analysis of tissues at 
a single-cell level. Here, we describe a robust method for the isolation of fibroblasts. The protocols described 
address some of the challenges associated with isolating and analysing fibroblasts from lung tissue. These results 
will help to inform future studies into the phenotype and function of this poorly-defined cell type.
Methods
Human samples. Lung samples were received fresh from patients undergoing surgery at Southampton 
General Hospital (TargetLung study; approved by NRES Committee South Central: Hampshire A, REC num-
ber 14/SC/0186. All research was performed in accordance with the appropriate regulations. Informed consent 
was obtained from patients or their legal guardians). Samples were transported in 5 ml serum-free Dulbecco’s 
Modified Eagle Medium (DMEM; Sigma-Aldrich) on ice directly (within 1 hour) to the laboratory for tissue 
disaggregation.
tissue disaggregation. Tissue samples were washed in phosphate-buffered saline (PBS) to remove excess 
blood, then incubated for five minutes in PBS with Amphotericin B (250 pg/ml; Gibco). Samples were incised 
10–15 times to relax the tissue and added to 5 ml of ‘complete’ DMEM (supplemented with L-glutamine (1% v/v; 
Sigma), foetal calf serum (10% v/v; Biosera) and penicillin-streptomycin (1% v/v; Sigma)). DNase (0.4 U/ml; 
Sigma) and the appropriate enzymatic mixture (Collagenase P, 3 U/ml; Sigma, Liberase DL, 0.25 U/ml; Sigma, 
Liberase TL, 1 U/ml; Roche, or Liberase TM, 0.25 U/ml; Sigma) were then added and samples were incubated at 
37 °C with agitation (200 rpm) for 15 or 60 minutes.
To disrupt larger pieces of tissue during the incubation period, sequential pipetting (using 25 ml, 10 ml 
and 5 ml pipettes) was performed at 15, 30 and 60 minutes. The resulting suspension was strained through a 
40 μm-pore filter (Corning), washed with 10 ml serum-free DMEM, and centrifuged at 450 g for 5 minutes. 
The pellet was re-suspended in 2 ml red cell lysis buffer (BioLegend) and incubated at 4 °C for 10 minutes. 
‘Complete’ DMEM (10 ml) was added, and the samples centrifuged at 450 g for 5 minutes. The resulting pellet was 
re-suspended in 1 ml of either cell suspension buffer (90% ddH2O; 9% Optiprep, Sigma; 1% PBS with 0.1% bovine 
serum albumin; BSA) for use in Drop-Seq, or fluorescence-activated cell sorting (FACS) buffer (PBS with 0.5% 
w/v BSA and 0.05% w/v sodium azide) for analysis by flow cytometry.
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Flow cytometry. Flow cytometry was used to determine the relative proportions of cell types in single-cell 
suspensions. Cells were re-suspended in FACS buffer at a concentration of 1 × 106/ml and stained with PE 
anti-CD31 (5 μg/μl; WM59), FITC anti-CD45 (10 μg/μl; H130), APC anti-CD90 (10 μg/μl; RPA-T4), Pacific Blue 
anti-EpCAM (5 μg/μl; 9C4), and 7-AAD (200 μg/μl) (BioLegend). Stained cells were analysed using a FACS Canto 
II (BD Biosciences). For all analyses, gating was performed as follows: 7-AAD vs. forward scatter area for live 
cells, forward scatter area vs. forward scatter height to exclude cell doublets, and side scatter area vs. forward scat-
ter area to exclude debris. Gating to identify populations positive for each antibody was performed using forward 
scatter area vs. the relevant fluorescent channel in comparison to fluorescence minus one controls. All data were 
analysed using the FlowJo software package (version 10.2; FlowJo, LLC).
Cell culture. Primary fibroblasts were isolated from the single-cell suspension generated following tissue disag-
gregation: the suspension was plated to the largest possible surface area at 100,000 cells/cm2 and incubated at 37 °C 
for 2 hours to allow cells to adhere. Following this, cells were washed in PBS (x3) to remove non-adherent (predom-
inantly immune) cells. Adherent cells were then cultured in ‘Complete’ DMEM in a humidified incubator at 37 °C 
and 5% CO2. Details of tissue culture substrate coating experiments are given in the supporting information.
RNA extraction. Cell pellets (from gel disaggregation or cell trypsinisation) underwent RNA extraction with 
DNase digestion using ReliaprepTM RNA Cell Miniprep System (Promega). RNA quantitation was performed 
using the NanoDrop Spectrophotometer (Thermo Fisher Scientific).
cDNA synthesis and quantitative real-time pCR. One microgram of RNA was reverse transcribed in 
a 20 μl reaction using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems), according to the 
kit’s protocol. cDNA was diluted to 2 ng/μl with UV-treated ddH2O and stored at −80 °C. Real-time polymerase 
chain reaction (PCR) was performed using TaqMan Real-Time PCR Assays (Thermo Fisher Scientific) and the 
QuantStudio 7 Flex Real-Time PCR system (Thermo Fisher Scientific) using two nanograms of cDNA.
Western blotting. Cells were lysed on ice in fibroblast lysis buffer (25 mM Tris-HCl pH 7.4, 150 mM NaCl, 
0.5% Triton-X, 20 mM NH4OH) with 1% protease inhibitor cocktail (Set 1; Calbiochem, Merck). An equal 
amount of protein from each sample was electrophoresed in 8% SDS-PAGE gels and electro-blotted to PVDF 
membranes (Millipore) as previously described43. Bound antibodies were detected using Supersignal West Pico 
or Femto Chemiluminescent Substate (Thermo Fisher Scientific) and visualised with the ChemiDoc-It Imaging 
System (UVP, LLC). Relative densitometry was performed using the Fiji software package. Antibodies used for 
Western blotting were to COL1A1 (NBP1-30054, 1:500, Novus Biologicals), Hsc-70 (sc-7298, 1:2000, Santa 
Cruz), SMA (A2547, 1:1000, Sigma) and IL-6 (ab6672, 1:500, abcam).
single-cell RNA sequencing and analysis. Single-cell RNA sequencing (scRNA-seq) was performed 
using a custom microfluidic platform44, as per Macosko et al.25 with slight adjustments. Filtering and clustering 
were predominantly carried out using standard functions included in the R Seurat package45. Further details are 
provided in the supporting information.
To filter low-quality events, a number of quality-control (QC) metrics were applied. The majority of these, 
including the number of unique molecular identifiers (nUMI) and percentage of reads mapping to mitochondrial 
genes (percent mito) have been described elsewhere previously1,3.
In addition, we calculated per-droplet estimates of ambient RNA capture. These calculations were based on 
the assumption that genes most highly expressed across each individual sample are, by probability, those most 
likely to account for prominent components of ambient RNA. Therefore, low-quality or empty droplets will show 
enrichment for these genes and a low total number of genes (nGene). To calculate these estimates, we first esti-
mated a lower threshold for nGene, based on the distribution of nGene across all events. This was taken as 2.5 
median absolute deviations (MADs) below the median for log10(nGene)46 (64 genes in this dataset). Using the raw 
DGE matrix for each sequenced sample, the top 64 highly expressed genes (by total number of reads) were iden-
tified across all cells as sample-specific Highly-Expressed Genes (ssHEGs). The percentage of total genes detected 
(ssHEGs:nGene.genes) or reads (ssHEGs:nGene.counts) per cell composed of these ssHEGs was calculated and 
used as a relative measure of ambient RNA incorporation.
Comparing gene expression of ex vivo and in vitro fibroblasts. Ex vivo fibroblasts were filtered by 
DCN expression (identified as a pan-fibroblast marker; cells with a DCN expression level of less than 1 were 
excluded) to exclude any misclassified cells. In vitro fibroblasts were expanded (as described in the “Cell Culture” 
section above) for 1 passage, then cultured in DMEM supplemented with L-glutamine (1% v/v) and FCS (1% v/v) 
for 5 days, following which they were collected by trypsinisation for Drop-Seq analysis. Cell lines (IMR-90 and 
H441) were grown to confluence in DMEM supplemented with L-glutamine (1% v/v) and FCS (1% v/v), then 
collected by trypsinisation for Drop-seq analysis. Cell filtering and clustering was then performed as above on 
each dataset prior to merging. This resulted in 559 cells for analysis (374 ex vivo fibroblasts, 46 in vitro NOF, 79 
in vitro cancer-associated fibroblasts; CAFs, 185 cells from cell lines).
statistics. Continuous data with a normal distribution were analysed using the unpaired two-tailed t-test. 
Where normalisation resulted in zero variance in the control sample, p values were adjusted using Welch’s correc-
tion to account for heteroscedasticity. Comparisons across multiple categories were performed using the ordinary 
one-way ANOVA. Prism (GraphPad) or R was used to perform statistical analysis and prepare figures. Unless 
otherwise stated, graphs show mean values +/− the standard error of the mean (S.E.M.). Significance values are 
denoted as follows: p ≥ 0.05: ns, 0.01 ≤ p < 0.05: *, 0.001 ≤ p < 0.01: **, 0.0001 ≤ p < 0.001: ***, p < 0.0001: ****. 
Where appropriate, Bonferroni correction was applied to control for multiple testing.
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Data Availability
Single-cell RNA sequencing data analysed in this study are available from Gene Expression Omnibus 
(GSE126111).
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